BioSpace News Archive

Business

LogicBio Therapeutics Announces Expansion of Leadership Team Through Multiple Key Hires

LogicBio Therapeutics today announced the expansion of its leadership team with the appointment of four seasoned industry leaders

January 2, 2018
·
3 min read
Business

CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd.) Enter Definitive Supply Agreement for Medical Cannabis

CanniMed Therapeutics Inc. and Up Cannabis Inc. announce that they have entered into a definitive Supply Agreement for a variety of medical cannabis strains.

January 2, 2018
·
7 min read
Biotech Bay

AgeX Therapeutics Identifies Genes Implicated in Tissue Regeneration and Cancer

AgeX today announced a newly-published peer-reviewed study that reveals genes implicated in tissue regeneration, cancer, and aging.

January 2, 2018
·
10 min read
FDA

Merck’s KEYTRUDA (pembrolizumab) Approved in Japan for Use in the Treatment of Patients with Urothelial Carcinoma That is Unresectable with Radical Surgery Who Have Progressed Following Cancer Chemotherapy

today announced that KEYTRUDA (pembrolizumab), the company’s anti-PD-1 therapy, has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) for the treatment of patients with radically unresectable urothelial carcinoma who progressed after cancer chemotherapy.

January 2, 2018
·
26 min read
Deals

Nuvo Pharma Acquires Global Ex-U.S. Product Rights and Existing Royalty Streams to Resultz From Piedmont Pharma

The transaction includes existing royalty streams in the Royalty Markets and all product and intellectual property rights in the Territory.

January 2, 2018
·
7 min read
Bone Index Announces AMA Issues New Reimbursement Code for Bindex Osteoporosis Measurement

Bone Index announces that the AMA has issued a new Category III CPT code* for Bindex measurement to help physicians in diagnosing osteoporosis.

January 2, 2018
·
2 min read
Biotech Bay

Bay Area’s DNAnexus Scores $58M to Accelerate Expansion

The cash will support expansion in translational informatics, clinical trials, and broadened use of biomedical data.

January 2, 2018
·
3 min read
BioCapital

Celgene Co-Founder Bags $23M for Johns Hopkins Spinout NexImmune

In conjunction with the financing, Tony Yao, MD, PhD, a Partner at ArrowMark Partners, will join NexImmune’s Board of Directors.

January 2, 2018
·
3 min read
Lifestyle Delivery Systems Announces Enhanced Provisional Patent Filing and Additional Trademark Applications in U.K. and E.U.

LDS announces the filing of an enhanced provisional patent for the CannaStrips technology and two additional applications for CannaStrips trademark protection in the United Kingdom and European Union to complement the Company’s current Canadian trademark application.

January 2, 2018
·
4 min read
BioCapital

Intrexon Corporation Annual CEO Letter

Randal J. Kirk, Chairman and Chief Executive Officer of Intrexon sent the following annual letter to his colleagues at Intrexon.

January 2, 2018
·
6 min read